方案论文:真实世界环境下通过数字健康开发慢性病管理智能线上线下模型的随机对照试验
该方案描述一项在韩国平昌郡开展的随机对照试验,评估线上线下(O2O)数字健康服务对糖尿病和高血压患者的有效性。研究分糖尿病组和高血压组,各组内随机分为干预组和对照组,干预包括个性化数字健康支持、持续数据监测和在线教育,主要结局包括HbA1c、收缩压和胆固醇水平。
要点
- 研究评估O2O数字健康服务模型对糖尿病和高血压慢性病管理的有效性。
- 糖尿病患者和高血压患者分别随机分为干预组和对照组。
- 主要结局包括HbA1c、收缩压和胆固醇水平,采用意向性治疗分析等方法。
核心结论
- 该方案概述了一种评估O2O数字健康服务模型用于慢性病管理的新方法,可为了解干预的细微效果提供见解,并强调未来干预量身定制的潜力。
- 通过评估真实世界有效性,本研究可为医疗政策提供信息、扩大O2O服务模型的应用范围,并识别可从数字健康服务中获益的其他慢性病。
研究设计与样本
- 本研究为随机对照试验,在韩国平昌郡开展,研究对象为糖尿病和高血压患者。
- 研究分为糖尿病和高血压两个主要参与者组,每组内参与者被随机分配到治疗组和对照组。
主要发现
- 干预包括个性化数字健康支持、持续数据监测和在线教育,由医疗专业人员提供初级保健。
- 主要和次要结局包括HbA1c、收缩压和胆固醇水平,采用意向性治疗分析、回归模型估计治疗效果,并调整基线协变量以提高精度。
- 亚组分析将探讨基于干预强度、合并症和医疗服务提供者等因素的治疗效果差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic diseases such as diabetes and hypertension pose significant health and economic challenges globally, and South Korea is no exception. Innovative digital health services have the potential to revolutionize chronic disease management by providing patients with real-time, personalized care and empowering them to take an active role in their health. There is a critical need to evaluate the effectiveness of such services. This protocol describes a randomized controlled trial that evaluates the effectiveness of an online-to-offline (O2O) digital healthcare service for patients with chronic diseases, specifically diabetes and hypertension, in Pyeongchang-gun. METHODS: This study presents a comprehensive protocol for the assessment of an online-to-offline (O2O) digital health service model aimed at managing chronic diseases. The study consists of two main groups of participants: those with diabetes and those with hypertension. Participants are randomized into treatment and control arms for each group. The intervention includes personalized digital healthcare support, continuous data monitoring, and online education, with primary care provided by healthcare professionals. To evaluate the primary and secondary outcomes-such as HbA1c, systolic blood pressure, and cholesterol levels-the study applies a range of statistical methods. These include intention-to-treat (ITT) analysis to account for all randomized participants, regression models to estimate the treatment effect, and adjustments for baseline covariates to improve precision. Subgroup analyses will explore variations in treatment effects based on factors such as intervention intensity, comorbidity, and healthcare provider. DISCUSSION: This protocol outlines a novel approach to evaluating the O2O digital health service model for chronic disease management. It offers insights into the nuanced effects of the intervention, highlighting the potential for tailoring future interventions for maximum benefit. By assessing its real-world effectiveness, this study can inform healthcare policies, expand the application scope of O2O service models, and identify additional chronic diseases that can benefit from digital health services. This research bridges the gap between theory and practice, contributing to evidence-based healthcare decision-making and improving patient outcomes in the era of digital health. TRIAL REGISTRATION: This study is registered at ClinicalTrials.gov of the US National Library of Medicine. The registration number is NCT06150508, and the registered date is 2023-11-29.
引用
- Shin JE, Choi J, Lee H, et al. Protocol paper: randomized controlled trial of the smart online-to-offline model development for chronic diseases management through digital health in real world setting. Trials. 2025. PMID: 39910545. doi:10.1186/s13063-025-08735-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。